Results 61 to 70 of about 12,798 (141)
Late Reverse Pupillary Block After Scleral Fixation With Yamane Technique: A Case Report
Case Reports in Ophthalmological Medicine, Volume 2025, Issue 1, 2025.Introduction The Yamane technique is a transconjunctival, sutureless method for scleral fixation of intraocular lenses (IOL) in cases lacking capsular support. While widely adopted because of its efficacy and safety, rare late complications such as IOL subluxation have been reported.
Maria J. Chaves-Samaniego +3 more
wiley +1 more source
Pakistan Armed Forces Medical Journal, 2013 Objective: To compare the effectiveness of prophylactically given 0.5% Timolol maleate and 0.2% Brimonidine tartrate in controlling increase in intraocular pressure after neodymium (Nd) : yttrium aluminum garnet (YAG) laser capsulotomy.
Muhammad Saeed Akhtar Malik +6 more
doaj +2 more sources
Iatrogenic Blepharoptosis: Multimodal Management and Treatment Technique With Botulinum Toxin Type A
Dermatology Research and Practice, Volume 2025, Issue 1, 2025.Blepharoptosis as an Aesthetic Complication Eyelid ptosis, or blepharoptosis, following esthetic treatment of the upper third with botulinum toxin Type A (BoNT‐A) is a complication with a variable incidence depending on the injector’s experience. Among unexperienced injectors, it ranges from 2.5% to 5.4% and approximately 0.51% to 1% in experienced ...
Rengifo-Palacios Jaime Alberto +4 more
wiley +1 more source
A Systematic Review of Ocular Complications Following Different Types of Covid‐19 Vaccines
Journal of Immunology Research, Volume 2025, Issue 1, 2025.Introduction More than 6 million deaths from the novel coronavirus, the Coronavirus disease 2019 (COVID‐19) infection, have prompted the development of several prophylactic vaccines of COVID‐19. This systematic review summarizes the ocular complications of various COVID‐19 vaccinations, diseases diagnosed, treatment, and risk factors.
Bahareh Ebrahimi +4 more
wiley +1 more source
Does Topical Brimonidine Tartrate Help NAION?
, 2002 Topical brimonidine tartrate has been reported to have a neuroprotective benefit for retinal ganglion cells following experimental elevation of intraocular pressure and optic nerve injury in the rat.
Hilary E. Fazzone, MD; Mark J. Kupersmith, MD
core
Brimonidine tartrate effect on retinal spreading depression depends on Müller cells
Revista Brasileira de Oftalmologia, 2014 Objective: Demonstrate the Brimonidine effect over Retinal Spreading Depression (SD). Brimonidine is an alpha-2–adrenergic receptor agonist, used in the management of glaucoma. Alpha2-agonists have been shown to be neuroprotective in various experimental
Vinícius Vanzan Pimentel de Oliveira +5 more
doaj +1 more source
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 7, Issue 12, Page 1207-1227, December 2024.Abstract Cognitive impairment affects around 19% of community‐dwelling older adults in the United States. Pharmacists can play a significant role in identifying and deprescribing cognitive‐impairing medications through cognitive‐focused medication reviews or as part of comprehensive medication management.
Jacob Stanton +4 more
wiley +1 more source
, 2004 PURPOSE: To identify demographic and clinical characteristics associated with the development of brimonidine tartrate 0.2%-induced ocular allergy.
Bonini, Stefano +6 more
core
, 2007 Background: To investigate the neuroprotective effects of topically applied brimonidine tartrate 0.2% (BMD), an alpha(2)-receptor agonist, on the retinal ganglion cell (RGC) layer and inner nuclear layer (INL) of rabbit retina in endothelin-1 (ET-1 ...
Oenol, Merih +4 more
core +1 more source
Clinical Ophthalmology, 2014 Toyoaki Tsumura,1 Keiji Yoshikawa,2 Tairo Kimura,3 Hirotaka Suzumura,4 Miwako Kawashima,5 Mami Nanno,6 Kiyotaka Ishijima,7 Ryuji Takeda8 1Fussa Hospital, Tokyo, Japan; 2Yoshikawa Eye Clinic, Tokyo, Japan; 3Ueno Eye Clinic, Tokyo, Japan; 4Suzumura Eye ...
Tsumura T +7 more
doaj